where should glp 1 patches be placed How to Use GLP-1 Patches: A Simple Step-by-Step Guide – Ledisa GLP-1 Patches': Do the Products

Tirzepatide (Mounjaro) for type 2 diabetes Mounjaro maintains coverage under most Anthem plans for type 2 diabetes

The Most Common Side Effects and Why They Happen Nausea This is the most frequently reported side effect and the one most likely to lead people to consider stopping the medication

Indications: Type 2 Diabetes Mellitus (monotherapy or add-on therapy) Especially useful in patients who cannot tolerate metformin or sulfonylureas Can be used in elderly and patients with mild renal impairment Approved Agents in India: Sitagliptin (Januvia) Vildagliptin (Galvus) Saxagliptin (Onglyza) Linagliptin (Trajenta) No renal dose adjustment needed Alogliptin (Nesina) Dosing: Once daily oral dosing Some agents require renal dose adjustment (except Linagliptin) Often combined with metformin or SGLT2 inhibitors Side Effects: Nasopharyngitis, headache GI upset (mild) Rare: Acute pancreatitis, severe joint pain, skin reactions Saxagliptin may slightly increase risk of heart failure in some patients Advantages Over Other Classes: Weight neutral Low risk of hypoglycemia Well tolerated in the elderly Convenient once-daily dosing Limitations: Modest HbA1c reduction (0.50.8%) Not effective in Type 1 Diabetes Less potent than GLP-1 analogs or SGLT2 inhibitors Conclusion: DPP-4 inhibitors are a safe, effective, and well-tolerated option for many patients with T2DM especially those needing an add-on to metformin or who can't tolerate injectables

Look at who was actually in the study: women with a BMI of 25 or higher

However, retatrutide may not be suitable for individuals with certain health conditions, such as severe gastrointestinal issues or heart problems

R., Tow, A